This year, one of my chief goals is to create opportunities for our members to become more engaged with the society’s activities and to enhance our interaction with stem cell researchers from under-represented countries. This will further our success in cultivating an inclusive, global society.

It is a great honor for me to assume the ISSCR Presidency during the 20th anniversary year of the Society’s founding. In the past 20 years, the ISSCR has embodied our shared passion for stem cell research. Thanks to all of you, the ISSCR became the world’s preeminent Society for stem cell research.

The ISSCR is pleased to announce Haifan Lin, PhD, Yale University School of Medicine, USA, as its President. Dr. Lin’s one-year term of office leading the global Society begins today.

As the ISSCR turns 20 this year, it is humbling to reflect on the exceptional stem cell achievements during that time and the many contribution of our Society. We can celebrate the curiosity, ingenuity, and persistence of our members that has yielded significant advances in stem cell research and regenerative medicine since those early days.

We have tremendous opportunities in the society for early career scientists both at the 2022 Annual Meeting and throughout they year, I thought it was the perfect time to share all of the ways to engage.

The International Society for Stem Cell Research (ISSCR) is pleased to announce the results of its 2022 election.

It should come as no surprise that as basic stem cell science is translated to the clinic, the breadth of our scientific programming and the needs of our global society are evolving.

A recent study published in the journal Stem Cell Reports has identified new ways to potentially enhance the SC-beta cell survivability through genetic manipulation of the cells.

Universally accepted characterization standards for pluripotent stem cell research are needed to improve the rigor and reproducibility of stem cell research. As the foremost international stem cell research society with a reputation for scientific and ethical rigor, the ISSCR is uniquely positioned to develop and propose research standards that can be widely adopted worldwide.

Last December, nearly 40 professionals with the U.S. Food and Drug Administration (FDA) gathered with ISSCR leaders to discuss advances in the development of stem cell therapies.

Stem cell scientists and leaders are recognized with the 2022 ISSCR Awards for their significant scientific contributions to stem cell research and regenerative medicine. Honorees will be recognized at ISSCR 2022 San Francisco + Virtual, the society's hallmark annual meeting 15-18 June 2022.